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The major immediate-early promoter (MIEP) of human cytomegalovirus is a remarkably strong RNA
polymerase II transcription control unit. We have identified and characterized a novel regulatory domain
associated with MIEP downstream from the initiation site of transcription. The downstream regulatory region
was first identified by analyzing a series of mutations in the 5' untranslated leader exon. This regulatory domain
was shown to enhance the number of functional initiation complexes without significantly altering the apparent
elongation rate by RNA polymerase II transcription. In addition, run-off in vitro transcription and DNA-
binding experiments identified two distinct downstream elements that specify the interaction of cellular
transcription factors. One of these elements contains a reiterated sequence motif, present twice within the
leader exon. The second element is an 18-bp sequence located at approximately nucleotide position +33 that is
conserved between strains of cytomegalovirus from different species. On the basis of two criteria, an
oligonucleotide competition assay and oligomerization upstream of the promoter, the binding of factors to the
conserved box was shown to be critical for mediating the level of transcription from MIEP. Two discrete
cellular nuclear proteins, designated LTF A and B (for leader transcription factor A and B binding factors),
were found to specifically recognize the conserved element. This study of promoter-proximal elements within
transcribed sequences demonstrates the recognition of the control domain at the DNA level that functions to
increase the number of committed RNA polymerase II transcription complexes.
Regulation of viral immediate-early (IE) gene expression
at the level of transcription constitutes a primary level by
which persistent viruses may regulate their state of activa-
tion in the host. We are interested in understanding the role
of cellular and viral transcription factors in coordinating
RNA polymerase II activity associated with the UL123-122
(7) major IE promoter (MIEP) of human cytomegalovirus
(HCMV), an important human pathogen. Since the MIEP is
dependent on the host cell transcriptional apparatus, it also
provides a particularly useful tool for detecting features of
the mammalian transcription control machinery.
Regulatory sequences of the MIEP offer a spectrum of
distinct upstream control domains encompassing an RNA
polymerase II promoter between +1 and -50 (17, 54), a
strong enhancer between -50 and -550 (3, 16, 52), a unique
sequence region (19) adjacent to a cluster of NF1/CTF
binding sites between -550 and -750 (19, 24, 28), and a
modulator sequence between -750 and -1145 (39, 49). The
modulator regulates, cell type specifically, transcription
from the MIEP in both a negative and positive manner (33,
39, 49). Conversely, the enhancer contains a complex array
of both strong constitutive and inducible regulatory elements
(6, 18, 26, 41, 46, 51). Certain members of these regulatory
modules contain binding sites for cellular transcription fac-
tors that have been characterized in other gene promoter
systems (reviewed in reference 20). However, the HCMV
enhancer modules also interact with a number of cellular
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transcription factors in cellular gene regulation that have yet
to be identified (18). Thus, the interfacing of MIEP with a
variety of sequence-specific transcription factors provides a
means to elucidate the function of a variety of cellular
regulatory proteins with relevance to the physiology of both
the cell and the virus.
The promoter-proximal downstream sequences of a num-
ber of viral and cellular genes transcribed by RNA polymer-
ase II have recently been recognized as containing transcrip-
tional regulatory elements (1, 8, 11, 22, 25, 29, 32, 35, 40, 53,
56, 57). In contrast to upstream regulatory domains, the
privileged location of cis-acting elements downstream of the
cap site provides the ability of trans-acting factors to operate
at two unique levels. First, these transcriptional elements
have the opportunity of being recognized at either the DNA
or the RNA level. Second, the level by which they affect
transcription can be at the rate ofRNA polymerase initiation
or elongation. Here, we report the identification and char-
acterization of a novel transcription control domain within
the 5' untranslated leader exon of the HCMV UL123 gene.
In this study we have attempted to define the molecular
requirements of the promoter-proximal downstream ele-
ments as well as the levels by which they may interact with
the transcriptional machinery.
MATERIALS AND METHODS
Plasmid constructions. The plasmid pUCExonl contains
the SacI-MaeIII fragment (MaeIII end of the fragment was
blunted by using mung bean nuclease) from the vector
pUCSstO.75, containing MIEP sequences from -19 to +715.
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The SacI-MaeIII fragment contains MIEP sequences from
-19 to +112 and was cloned into the pUC19 vector between
the Sacl and the Hindlll sites. The recombinant plasmid
pMIEP(-1145/+7)CAT contains the PstI-Sau3A fragment
of MIEP fused to the cat gene as described previously (26).
The construction of pMIEP(-1145/+54)CAT has been de-
scribed before (15). The vector pMIEP(-1145/+112)CAT
was constructed by replacing the SacI-SmaI fragment of
pMIEP(-1145/+7)CAT with the above-mentioned Sacl-
MaeIII fragment. The plasmid pEXO1 was engineered by
ligating complementary synthetic oligonucleotides, AGCTT
GACCTCCATAGAAGACCC and GGGTGTCTTCTATGG
AGGTCA, into the pUC19 vector between the Hindlll and
the SmaI sites. A similar strategy was used for the construc-
tion of the series of point mutations in the conserved box,
resulting in plasmids pEXM1 through pEXM5. The specific
oligonucleotides are shown in Fig. 7. The construction of the
core promoter pMIEP(-66/+7)CAT was achieved by re-
placing the EcoRI-SacI fragment from pRR56/5 (kindly
provided by B. Fleckenstein) with the EcoRI-SacI fragment
from pMIEP(-1145/+7)CAT. The filled-in EXO1 oligonu-
cleotide was cloned in multiple copies upstream of the core
promoter by ligation into blunted HindIII-restricted pMIEP
(-66/+7)CAT vector. The dimers of EXO1 in the sense and
antisense orientations are termed p2CB(S)CAT and p2CB
(AS)CAT, respectively. All cloning steps were confirmed by
directly sequencing the plasmid DNAs and by restriction
endonuclease cleavage.
Transfection assays. Transfections were performed by the
calcium phosphate precipitation method on monolayers of
HeLa S3 cells which were approximately 80% confluent.
Cells were harvested and assayed for chloramphenicol ace-
tyltransferase (CAT) activity as described by Gorman et al.
(21). In each assay, 200 pug of protein was assayed for CAT
activity at 37°C for different time intervals between 5 and 25
min. The reaction consisted of a total volume of 150 ,u
containing 0.47 M Tris-HCl (pH 7.8), 0.53 mM acetyl coen-
zyme A, 0.1 ,uCi of [14C]chloramphenicol (40 to 50 mCi/
mmol), and cell extract. The products were extracted with
ethyl acetate, separated by ascending thin-layer chromatog-
raphy, and quantitated by scintillation counting.
Nuclear extract preparation. Nuclear extract from HeLa
S3 cells was prepared as described by Dignam et al. (9), with
the exception that all buffers contained 10 puM each leupep-
tin, pepstatin, and aprotinin in addition to 0.5 mM phenyl-
methylsulfonyl fluoride (PMSF). Protein concentration was
determined by the Bradford method (5).
In vitro transcription and competition assays. The tran-
scription reaction conditions (in 25 ,ul) were as described by
Ghazal et al. (16). Routinely, poly(U) polymerase activity
present in the extracts was used as an internal control to
account for variability during the workup of the RNA
samples. Experiments designed to dissociate the initiation
and elongation steps were based on the studies of Hawley
and Roeder (23). For these experiments, extracts were
incubated for 20 min at 25°C before the addition of template
DNA and ribonucleotides (50 ,uM each CTP, GTP, and ATP
and 10 puM UTP). These modified conditions limit the ability
of the transcription system to support more than one round
of transcription (23). Preinitiation transcription complexes
were assembled on pMIEP(-1145/+7)CAT and pMIEP
(-1145/+112)CAT templates by incubating the DNA tem-
plates on ice for 10 min. A rapid start complex was initiated
by incubating the preinitiation reaction at 30°C for 2 min.
Ribonucleotides, described above, were added, rapidly fol-
lowed (within 30 s) by the addition at room temperature of
Sarkosyl as indicated in the legend to Fig. 3. Elongation
reactions were allowed to proceed for 15 min at 30°C and
processed as described below.
The in vitro transcription oligonucleotide competition
assay was performed as described previously (18). The
human immunodeficiency virus (HIV) long terminal repeat
(LTR) template pBennCAT was truncated at the EcoRI site
downstream from the initiation site of transcription and used
in the in vitro transcription system as described before (34).
In vitro transcription oligonucleotide competition experi-
ments with the templates pMIEP(-1156/+112)CAT and
pBennCAT were performed independently. The RNA prod-
ucts synthesized from these experiments were pooled and
coelectrophoresed. All transcription reactions were allowed
to proceed for 15 min, after which the in vitro-synthesized
RNA was processed by stopping the reaction with 100 p1l of
1% Sarkosyl-10 mM Tris-HCI (pH 8.0)-0.2 M NaCl-40 p.g of
tRNA per ml. The samples were phenol extracted once,
followed by an ether extraction, and then ethanol precip-
itated. The pelleted nucleic acids were resuspended in 8 p.l of
90% formamide-1 x gel buffer (0.1 M Tris-borate, 2 mM
EDTA [pH 8.3])-0.1% bromophenol blue-0.01% xylene cy-
anol and heated to 90°C for 5 min. Resuspended RNA
transcripts (4 p.l) were electrophoretically separated on a 4%
sequencing gel and visualized by exposure of the dried gels
to Kodak X-Omat AR film with an intensifying screen at
-70°C. For quantitation, the run-off transcripts were excised
from the dried gel, and the amount of Cerenkov radiation per
specific transcript band was determined.
DNase I protection analysis. The exon 1 fragment for
DNase I protection studies was prepared from the
pUCExonl vector containing the MIEP sequences from -19
to + 112. Endonuclease cleavage at the Hindlll and EcoRI
sites of pUCExonl was used to release the fragment from
the vector. The Hindlll and EcoRI sites were selectively
dephosphorylated by treatment with alkaline phosphatase.
The fragments were subsequently gel purified and labeled
with polynucleotide kinase and [-y-32P]ATP. The conditions
for the DNase I protection experiments were as described
previously (16).
Gel mobility shift assay. The gel mobility shift assay and
binding reaction conditions were performed as described
before (17). The cloned double-stranded oligonucleotides
from pEXO1, pEXM1, pEXM2, pEXM3, pEXM4, and
pEXM5 were released from the vector with the endonu-
cleases HindlIl and SmaI and then gel purified. The double-
stranded oligonucleotide probes were end-labeled with
[a-32P]dATP by using Sequenase version 2.0 (USB). Ap-
proximately 0.1 to 0.5 ng of radiolabeled probe was used per
binding reaction.
Photoactivated DNA-protein cross-linking. Photoactivated
DNA-protein cross-linking in solution was performed by
specifically binding the radiolabeled EXO1 fragment (0.5 ng)
with 20 pug of crude nuclear extract and irradiating the
complex with 80,000 ,uJ by using UV Stratalinker 1800. In
situ photoactivated DNA-protein cross-linking was achieved
by resolving the above specific complexes in a 2% low-
melting-point agarose gel mobility shift, irradiating the gel
with 240,000 puJ. The nucleoprotein complex was visualized
by autoradiography, and the bound and free DNA were
excised, boiled for 5 min in the presence of 1% sodium
dodecyl sulfate (SDS) and P-mercaptoethanol, and directly
loaded on an 8% Laemmli gel. 14C-methylated protein mark-
ers (myosin [200 kDa], phosphorylase b [100 and 92.5 kDa],
bovine serum albumin [69 kDa], and ovalbumin [46 kDa])
were purchased from Amersham.
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FIG. 1. In vitro transcription run-off assays with different con-
centrations of DNA templates pMIEP(-1145/+7)CAT (0), pMIEP
(-1145/+54)CAT (0), and pMIEP(-1145/+112)CAT (A) truncated
with EcoRI, PvuIl, and PvuII, respectively. The transcription
reactions were performed, processed, and subjected to polyacryl-
amide gel electrophoresis as described under Materials and Meth-
ods. The specific run-off transcripts were excised from the gel, and
the amount of transcript was determined as described under Mate-
rials and Methods.
RESULTS
Exon 1 sequences contain a transcription control domain.
The importance ofDNA sequences that lie downstream from
the start site of transcription in controlling the level of
expression from MIEP is not known. Since this region may
contain a unique target for regulating viral gene expression,
we sought to explore the involvement of downstream se-
quences in regulating MIEP activity by using an RNA
polymerase II in vitro transcription system. The de novo
synthesis of RNA in the in vitro assay permits one to
elucidate the requirement of this control domain in transcrip-
tion. The DNA templates used in this assay comprised
deletion mutations in the 5' untranslated leader exon (exon
1) fused to the reporter gene for CAT (cat). The plasmids
pMIEP(- 1145/+7)CAT, pMIEP(- 1145/+54)CAT, and
pMIEP(-1145/+112)CAT, containing MIE leader exon 1
sequences deleted at +7, +54, and + 112, respectively, were
assayed in HeLa S3 transcriptionally active nuclear extracts.
In order to obtain similar-length transcripts, pMIEP
(-1145/+7)CAT was resected with EcoRI, while pMIEP
(-1145/+54)CAT and pMIEP(-1145/+112)CAT were re-
sected at the PvuII site, resulting in run-off transcripts
truncated 263, 220, and 265 nucleotides downstream of the
initiation site, respectively. A significant enhancement of
transcription was observed in those constructs containing
exonic sequences (Fig. 1). The transcription enhancement
for pMIEP(-1145/+54)CAT relative to pMIEP(-1145/+7)
CAT was threefold and for pMIEP(-1145/+112)CAT rela-
tive to pMIEP(-1145/+54)CAT was twofold (Fig. 1). There-
fore, the enhanced level of transcription in vitro mediated by
the complete exon 1 sequences was approximately sixfold.
In support of the in vitro run-off experiments, in vivo
transfection assays with the deletion mutant templates also
demonstrated an augmentation of MIEP activity by as much
pMIEP (-1 145:+7) CAT pMIEP (-1145i+54) CAT pMIEP (l1145;+1 12) CAT
***,,, .,**
I 0 Ia .
5 10 15' 25' 5 10 15 25 5 10 15 25
Time iminutes,
FIG. 2. Kinetic analysis (from 5 to 25 min) of CAT enzyme
activity from deletion mutant constructs pMIEP(-1145/+7)CAT,
pMIEP(-1145/+54)CAT, and pMIEP(-1145/+112)CAT containing
3'-end deletion endpoints at +7, +54, and + 112, respectively. These
cat constructs were transiently transfected into HeLa S3 cells;
extracts were prepared 48 h later, and CAT activity was determined
by thin-layer chromatography.
as 15- to 18-fold (Fig. 2). The deletion mutations suggest that
the 5' untranslated leader exon of the MIE gene may interact
with nuclear factors to promote the process of transcription
complex formation and elongation. The additive stimulatory
effect seen with increasing amounts of the leader sequences
suggested the involvement of multiple elements.
Leader control domain enhances the rate of transcription
initiation by RNA polymerase II. The conditions used for the
in vitro transcription were not completely limiting for a
single-round transcription (see Materials and Methods), and
reinitiation events could still have occurred (Fig. 1). If the
elongation rate is enhanced by the exonic leader sequences,
then presumably RNA polymerase II molecules can begin a
new round of initiation sooner. Consequently, under these
conditions, the observed effect on the number of initiations
could be indirect. To determine whether transcription com-
plexes which formed on the different templates were primar-
ily initiation or elongation complexes, the effect of the
anionic detergent Sarkosyl on specific transcription was
examined. Elongation of committed transcription complexes
is insensitive to the presence of Sarkosyl (0.02%), whereas
transcription complexes formed prior to elongation are dis-
rupted (see Materials and Methods). Therefore, the relative
rates of initiation of transcription can be dissociated from the
rates of transcription elongation. Under these defined con-
ditions for a single round of transcription in the in vitro
transcription assay, pMIEP(-1145/+112)CAT gave an ap-
proximately four- to fivefold increase in the level of RNA
synthesis compared with pMIEP(-1145/+7)CAT (Fig. 3).
Furthermore, a comparison of the level of transcription for
this experiment in the presence and absence of Sarkosyl
demonstrated that reinitiation did not occur. We therefore
conclude that the enhanced level of transcription, mediated
by the leader exon sequences, is due to the rate of initiation
complex formation.
Binding of nuclear proteins to multiple sequence motifs in
exon 1. To explore whether sequence-specific factors bind to
defined exonic leader elements, DNase I protection experi-
ments were performed with the transcriptionally active
extract. Strong protection was observed with both the sense
and antisense strand sequences between +53 and +78 (Fig.
4). Weaker interactions were detected between +34 and +54
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Human +33 ITGACCTCCATAGAAGACAI
Simian +25 GGAGCTCCATTGGAAGAGA
Mouse +17 TGACCACCGTAGAACGCA
FIG. 5. Conserved box sequence from the MIE genes of human
(3), simian (28), and murine (10) CMV genomes. The location of
these sequences downstream from the cap site within the 5' untrans-
lated exon 1 is indicated.
FIG. 3. Single-round RNA chain initiation from pMIEP(-1145/
+7)CAT and pMIEP(-1145/+112)CAT. These DNA templates
were restricted with EcoRI and PvuII, respectively, and used in the
in vitro transcription assay under limiting conditions for reinitiation
as detailed in Materials and Methods. In lanes 2 and 4. Sarkosyl was
added to a final concentration of 0.02% 30 s before nucleotide
additions. Water instead of Sarkosyl was added in lanes 1 and 3.
Quantitation of specific transcript was achieved by Cerenkov count-
ing of the excised transcript band from the dried gel.
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for both strands, while weak interactions from +79 to +91
were only observed for the antisense strand (Fig. 4). In
addition to the protected regions, hypersensitive sites of
DNase I cleavage were observed in proximity to the pro-
tected sequences (Fig. 4). Interestingly, the majority of these
sites are located on the sense strand and occur at fairly
regular intervals, which may suggest an altered conforma-
tion of the DNA helix.
The binding sites between +51 and +91 contain a reiter-
ated sequence motif which can be represented as either a
direct or an inverted repeat (Fig. 4). A computer-assisted
search revealed a conserved sequence element associated
with the + 34 to + 54 binding site (Fig. 5). All of the
downstream elements required for MIEP transcriptional
activity map within the sites of protein-DNA interaction. We
cannot rule out that additional sequences undetected in this
study may be involved. However, a good correlation is
observed between the binding sites for nuclear protein(s) and
the transcriptional activity of the deletion mutations. This
strongly supports the conclusion that the binding of these
sequence-specific factors is responsible for the increased
rate of initiation of transcription.
Recognition of a conserved sequence element by discrete
cellular factors. The conserved box-binding site between
+34 and +54 was only weakly protected in the DNase I
protection experiments (Fig. 4). It is possible that this
binding activity represents an extension of the strong down-
stream footprint or that the conserved box may bind an
independent factor(s). The latter suggestion is supported by
FIG. 4. (A) DNase I footprinting of cellular proteins interacting
with the 5' untranslated leader exon of MIEP. HeLa S3 nuclear
proteins were analyzed for sequence-specific DNA-binding proteins
interacting with exon 1 sense and antisense strands by DNase I
footprinting as described under Materials and Methods. Lanes 1 and
4 demonstrate the DNase I digestion pattern in the presence of
nuclear proteins. Lanes 2 and 3 demonstrate a control reaction
containing DNase I alone. Lane M is an A+G Maxam and Gilbert
sequence ladder of the exon 1 fragment. Brackets mark regions of
DNase I protection, with the location indicated by the number of
base pairs downstream from the cap site. Horizontal lines indicate
DNase I-hypersensitive sites that were reproducibly observed. (B)
Sites of protein-DNA interaction on the MIEP leader exon region.
Numbers represent the distance in base pairs downstream from the
transcription start site (+1). Sequences protected from DNase I
cleavage are marked by white letters on a black background.
Vertical arrows denote positions of enhanced protein-induced
DNase I cleavage in vitro. Repeated sequence elements are desig-
nated by horizontal arrows, and the conserved sequence element is
boxed.
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FIG. 6. Nucleoprotein complexes associated with the conserved
box in the gel mobility shift assay. Nuclear extract from HeLa S3
cells was incubated with the EXO1 oligonucleotide probe indicated
by the sequence. Capital letters of the sequence mark nucleotides
within the exon 1, while lowercase letters refer to linker sequences.
P marks the location of free probe. Lane 1, Probe in the absence of
specific nuclear proteins; lanes 2 to 6, probe in the presence of 5 ,ug
of HeLa cell nuclear proteins; lanes 3 to 6, the binding reactions
contained a 50-fold molar excess of competitor DNAs. The compet-
itor DNA fragments were (lane 3) unlabeled EXO1, (lane 4) MIEP
fragment -19 to +54, (lane 5) MIEP fragment -19 to +112, and
(lane 6) MIEP fragment -19 to +7. Arrows indicate specific
nucleoprotein complexes.
the observation that the deletion mutant pMIEP(-1145/
+54)CAT retains stimulatory activity. To examine in more
detail whether the conserved box can independently bind
specific nuclear proteins, a mobility shift assay was per-
formed. The assay used a synthetic double-stranded oligo-
nucleotide (EXO1) corresponding to the conserved box.
Figure 6 clearly shows that the conserved box can indepen-
dently interact with nuclear proteins and supports the DNase
I protection experiment results.
In this experiment, a complex pattern is observed, sug-
gesting that multiple nucleoprotein complexes may be asso-
ciated with the conserved element. Competition experiments
were used to establish the sequence specificity of these
complexes. Three predominant complexes (indicated by the
arrows in Fig. 6) were inhibited from forming by an excess of
the unlabeled EXO1 oligonucleotide, a MIEP fragment con-
taining sequences between -19 and +54 and the exon 1
fragment containing sequences from -19 to + 112. However,
a fragment containing sequences from -19 to +7 did not
inhibit the formation of the three specific nucleoprotein
complexes (Fig. 6, lane 6). The complex indicated by the dot
represents a single-stranded component of the oligonucleo-
tide that is specifically band shifted but was not reproducibly
observed. The two slower-migrating complexes were occa-
sionally resolved as a single band and are designated to-
gether as complex A (Fig. 7). We refer to the predominant
fast-migrating band as complex B. Furthermore, the cell
type distribution of the conserved box complexes A and B
appears to be constitutive in a wide variety of cells, including
Jurkat, CEM, U937, H9, Raji, B, HepG2, human foreskin
fibroblasts, NT2-D1, and T47D cells (data not shown).
However, the functional activity of this element and its
cognate binding factors in these respective cell types re-
mains to be determined.
F B F BF B F B F B F 8
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FIG. 7. Binding of nuclear proteins to the mutated conserved
box templates. The sequence of the wild-type motif (EXO1) is
shown below the figure, and the point mutations present in each of
the respective mutant templates are indicated immediately below.
The name of the template in each line is indicated. The locations of
the A and B complexes formed with the wild-type and mutant
templates are indicated on the left-hand side and boxed in the EXO1
sequence. F represents free probe in the absence of nuclear pro-
teins, while B represents bound probe in the presence of nuclear
proteins.
The sequence requirement for the formation of the con-
served box complexes was investigated further in the gel
retardation experiments with a series of radiolabeled tem-
plates containing point mutations throughout the conserved
box motif (Fig. 7). Formation of complex A (Fig. 7) was
completely inhibited by point mutations at positions +34,
+35, +37, +39, and +40 (mutations EXM1 and EXM2).
These observations indicate that complex A recognizes the
TGACCTCC motif of the conserved box. In contrast, com-
plex B was completely inhibited by point mutations at
positions +37, +39, and +40 (EXM2), while mutations at
+44, +45, +46, +47, +49, and +50 had little effect (EXM3
and EXM4). We conclude from these observations that
complex B recognizes sequences between +37 and +43,
representing the CCTCCATA motif. Mutations at +44, +45,
and +46 (EXM3) slightly increased the formation of com-
plexes A and B, while additional mutations at positions +47,
+49, and +50 slightly decreased complex A formation. The
observation that sequence outside the recognition motif
influences the extent of binding indicates that the sequence
context of complex A and B binding may be important.
Alternatively, a direct interaction may exist for complex A
and B with sequences located between positions +44 and
+50. Importantly, complex A was exclusively inhibited from
forming by mutations at +34 and +35 (EXM1), while com-
plex B was unaffected, strongly suggesting different proteins
in the formation of complex A and B that appear to interact
with closely overlapping sequences. The complexes A and B
formed on the mutated templates could be inhibited by the
wild-type (EX01) template, demonstrating that no new
complex was formed (data not shown).
The discrete nature of complexes A and B was further
supported by photoactivated UV cross-linking experiments
in solution, which identified two distinct proteins of 50 ± 4
and 74 + 4 kDa, respectively, that recognized the conserved
box (Fig. 8). Competitor fragments containing the conserved
box-binding site specifically competed for the 74- and 50-kDa
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FIG. 8. Photoactivated UV cross-linking of the conserved box-
binding sequence to HeLa cell nuclear proteins. Lanes 1 and 2 and
lanes 3 and 4 represent UV cross-linking in solution and in situ,
respectively. Lanes 2 and 3 are UV-cross-linked products in the
presence of specifically bound proteins. The reaction conditions for
cross-linking are detailed in Materials and Methods. M, Marker
proteins. Specific polypeptides (arrows) in this assay are shown by
their determined molecular masses of 74 ± 4 and 50 ± 4 kDa.
proteins in the solution cross-linking experiment (data not
shown). The amount of label in these species increased with
increasing UV irradiation, with the optimal irradiation de-
tected between 80,000 and 100,000 ,J (data not shown).
Labeled species were not observed when the probe DNA
alone was irradiated (Fig. 8) or when UV irradiation was
omitted (data not shown).
An alternative strategy was also used to identify the
molecular weights of the proteins bound to the conserved
box. In this experiment, the double-stranded EXO1 oligonu-
cleotide was bound with nuclear proteins, and the specific
nucleoprotein complexes were then resolved in a 2% agarose
gel. In the agarose gel, only a single nucleoprotein complex
was developed with the EXO1 probe that could be specifi-
cally competed with by unlabeled EXO1 (data not shown).
The resolved complex was irradiated in situ, excised, and
electrophoretically separated on an SDS-polyacrylamide gel
(Fig. 8). Two specific complexes which comigrated at ap-
proximately the distance of the specific products from the
solution UV cross-linking experiment were detected (Fig. 8).
Since the covalent attachment of short oligonucleotides to
proteins has only a minor effect on the mobility of these
proteins in SDS-polyacrylamide gels, these experiments
indicate that the molecular weights of the proteins identified
above are close to the apparent molecular weights predicted
by the gels.
Conserved sequence box functions at the DNA level. To
investigate whether the conserved box is recognized at the
DNA level, the EXO1 oligonucleotide was dimerized up-
stream of the core promoter (see Materials and Methods).
Run-off in vitro transcription reactions were performed with
pMIEP(-66/+7)CAT, p2CB(S)CAT, and p2CB(AS)CAT
(Fig. 9). To control internally for variability during process-
ing of samples, poly(U) polymerase activity present within
the nuclear extracts was assayed simultaneously during the
transcription reactions (Fig. 9). Transcripts were quantitated
relative to the poly(U) polymerase RNAs by scintillation
counting of bands. A 2.5- and 1.8-fold stimulation in tran-
scription was observed for p2CB(S)CAT and p2CB(AS)CAT
relative to pMIEP(-66/+7)CAT, respectively (Fig. 9). A
moderate increase was also observed with the monomers,
although there was a strong requirement for multiple se-
quence elements for optimal activity. We conclude that the
FIG. 9. Oligomerization of conserved box (EXO1) upstream of
the core promoter, pMIEP(-66/+7)CAT. Dimers of EXO1 in the
sense and antisense orientation are present within the constructs of
p2CB(S)CAT and p2CB(AS)CAT, respectively. Run-off in vitro
transcription assays were performed with EcoRl-truncated tem-
plates of: lane 1, pMIEP(-66/+7)CAT; lane 2, p2CB(AS)CAT; and
lane 3, p2CB(S)CAT. The specific run-off transcripts are indicated
by the IS arrow, and the internal control [poly(U) polymerase-
labeled RNA] are indicated by the IC arrow. Quantitation of specific
transcription was achieved by cutting out specific transcript bands
and Cerenkov counts were normalized to the respective IC-labeled
bands.
conserved box can act independently upstream of the pro-
moter and thus is recognized at the DNA level.
To examine further whether the binding of the factor(s) to
the DNA sequence of the conserved box plays a role in
activating MIEP, we performed in vitro transcription oligo-
nucleotide competition experiments with the duplex deoxy-
oligonucleotide, EXO1. Increasing molar amounts of EXO1
relative to the concentration of pMIEP(-1145/+112)CAT
inhibited the specific level of transcription approximately
threefold (Fig. 10). A nonspecific competitor oligonucleotide
did not inhibit the level of transcription (data not shown). In
addition, equivalent molar amounts of EXO1 did not affect
specific transcription from the HIV-1 LTR (Fig. 10). We
conclude from these experiments that the conserved box
sequence is recognized at the DNA level by a sequence-
specific transcription factor(s) necessary for the activation of
MIEP. An examination of the effect of the mutant duplex
oligonucleotides in the in vitro transcription competition
assay was performed. Those mutants which were bound by
both complexes A and B competed efficiently (EXM3 and
EXM4), while those that bound neither (EXM2 and EXM5)
or only one (complex EXM1) failed to compete significantly
(Fig. 11). Thus, a direct correlation is observed between
binding of complexes and function of the conserved box. In
particular, these data clearly demonstrate the requirement
for complex A in the activation of MIEP.
DISCUSSION
Leader transcription control domain of MIEP. In this study
we have identified a positive transcriptional control domain
within the 5' untranslated leader region, exon 1, of the
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FIG. 10. In vitro transcription oligonucleotide competition assay
with EXO1 oligonucleotide and HIV LTR (pBennCAT) and pMIEP
(-1145/+112)CAT templates truncated at the EcoRI and Pvull
sites, respectively. Reactions were performed as described in Ma-
terials and Methods. Arrows mark the specific transcripts from
pBennCAT (LTR) and from pMIEP(- 1145/+112)CAT (MIEP).
Lane 1, Transcription reactions in the absence of competitor DNA;
lanes 2 and 3, reactions in the presence of EXO1 competitor at 20-
and 50-fold molar excess over the template DNA, respectively.
HCMV IE UL123-122 gene. This promoter-proximal down-
stream domain functions by increasing the number of com-
mitted RNA polymerase II transcription complexes. In the
presence of a very strong enhancer, this leader region can
contribute significantly to the level of expression from MIEP
by as much as 18-fold and 6-fold in vivo and in vitro,
respectively.
The activity of the leader transcription control domain is
mediated by sequence-specific DNA-binding proteins which
we designate LTFs (leader transcription factors). The bind-
ing of these factors detected in this study occurs with
sequences between +33 and +91. The sequences bound by
specific DNA-binding proteins between +33 and +51 repre-
sent a sequence element that occurs in approximately the
same location downstream from the MIEP cap sites in
strains of CMV from different species (Fig. 5). This con-
served element interacts with two discrete nucleoprotein
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FIG. 11. Effect of the different mutant conserved box oligonu-
cleotides on the transcriptional activity of pMIEP(- 1145/+ 112)CAT
in an in vitro competition assay. The amount of competitor is
expressed as a molar ratio with respect to the template. Quantitation
was achieved by scintillation counting of transcripts and normalized
to the HIV LTR transcripts. The relative transcriptional activity of
a template is plotted as a function of increasing competitor/template
molar ratio and expressed as a percentage of its transcriptional level
in the absence of competition.
complexes, designated LTF A and B, that contact closely
overlapping sequences. Here we present evidence for the
requirement of LTF A activity in regulating MIEP from
oligonucleotide in vitro transcription competition experi-
ments with the mutant conserved box templates.
The conservation of a sequence motif in approximately the
same position within the 5' untranslated leader exon 1 of the
CMV MIEPs suggests an important biological function of
these sequences. This homology is particularly striking in
the case of murine CMV, in which the conserved box
represents the only significant identity within the complete
exon 1 sequences (10). A more extensive homology is
detected between the human and simian exon 1 sequences,
which begins at the conserved box and extends to the repeat
motifs between nucleotides +52 and +91 (28). The oligonu-
cleotide competition experiments and oligomerization up-
stream of the promoter, in combination with the deletion
mutation analysis, strongly support the conclusion that the
conserved box plays an important role in MIEP transcrip-
tional activity. Although we have in this study focused on
the conserved box, we anticipate that additional elements
within exon 1 may be involved in regulating MIEP transcrip-
tion activity, which will be the subject of future investiga-
tion. It is also possible that exon 1 sequences contain
elements which control posttranscriptional events such as
the stability of the RNA molecule. Alternatively, LTFs may
be involved in negating repression of transcription mediated
by nucleosomal cores and histone Hi. We propose, there-
fore, that the leader domain may contribute a key target for
regulating viral activation in a permissive cell. It is important
to note that although HeLa cells are nonpermissive for
HCMV growth, the permissive human foreskin fibroblast
cells contain LTF activity (unpublished observations). To
demonstrate the functional activity of LTFs in human fore-
skin fibroblast cells, it will be necessary to establish a
reconstituted in vitro transcription system from these cells.
In this connection, it will ultimately be necessary to target
this regulatory domain for mutagenesis in the viral genome in
order to assess its importance during the viral replication
cycle.
At present, it is unclear whether the conserved box-
binding factors occur downstream of promoters for cellular
genes. The ability of the conserved box to function upstream
of the MIEP promoter strongly suggests that its position
downstream may not be a requirement in cellular promoters.
However, LTF binding sites between +52 and +91 of the
MIEP bear some resemblance (approximately 70% identity)
to sequences located shortly downstream of the initiation
sites for the mouse dihydrofolate reductase (11) and rpL32
(22) genes. These cellular sequences are in a region required
for promoter activity and also have been shown to bind
cellular proteins (11, 22).
Interactions with the transcriptional machinery. We con-
clude that the leader transcription control domain is distinct
from the core promoter, since correctly initiated complexes
are detected in the absence of the leader region. In this
respect the leader control domain is distinct from the internal
control domains of RNA polymerase I and III genes.
In general, promoter-proximal downstream transcriptional
elements may be classed as elements which are recognized
at either the RNA level or the DNA level. Within these
classes, two mechanistic distinctions can be made which
include those elements which affect initiation and those that
affect translocation of the transcription complex. In some
cases, a particular downstream promoter-proximal region
may encompass all of the above characteristics, as is exem-
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plified by the intensely studied HIV LTR (2, 4, 12-14, 27,
29-31, 36, 42-45, 47, 48, 50, 55). An increasing number of
RNA polymerase II promoters have been shown to contain
essential DNA sequences located downstream of the initia-
tion site of transcription, although little is known about the
mechanism of action (1, 8, 11, 13, 22, 25, 29, 32, 35, 40, 53,
56, 57). However, in the case of the simian virus 40 late
promoter, it has been shown that the downstream element
increases the number of functional preinitiation complexes
assembled at the promoter without altering the apparent rate
of complex assembly (1). It was suggested that in the
absence of the downstream DNA element, preinitiation
complexes were partially assembled but were not transcrip-
tionally competent. In the study presented here on the
MIEP, we have described the activity of a transcriptional
downstream domain that appears to be mediated by a
sequence-specific DNA-binding protein(s) that affects the
rate of initiation complex formation. Although we have not
measured the rate of complex assembly, we have shown that
the downstream domain enhances the number of competent
initiation complexes. These observations raise a number of
interesting possibilities by which the transcription factors
may interact with the general transcription machinery. For
example, the binding of LTFs to exon 1 may function in the
stabilization or recruitment of the initiated promoter com-
plex. In this example, such interactions may exist transiently
by interacting with the preinitiation complex, disengaging
upon committed complex formation, and recycling to the
next preinitiation complex. Alternatively, the LTFs may be
engaged with both the preinitiation and committed transcrip-
tion complexes. More interestingly, LTFs may function by a
novel mechanism of action involving a quaternary complex
interaction (DNA-RNA-LTF-transcription complex) as op-
posed to a ternary complex (DNA-LTF-transcription com-
plex). These different possibilities remain speculative and
must await further purification and isolation of the LTFs and
their analyses in the reconstituted in vitro system.
In conclusion, we have described the first example of a
transcription control domain, outside overlapping transcrip-
tion units, internal to a CMV gene in which the viral genome
length is approximately 240 kb. We propose that the leader
control domain of MIEP may constitute a key target for
regulating viral activation. This downstream control domain
functions by increasing the number of initiation complexes at
the promoter and involves the interaction of at least two
novel cellular sequence-specific factors. The binding of these
factors to their target DNA does not appear to impede the
apparent rate of elongation by RNA polymerase II. Finally,
this transcription control region underscores the diversity of
control domains associated with mammalian RNA polymer-
ase II transcription units.
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